Moleculin Biotech, Inc. (MBRX) NASDAQ
2.40
-0.24(-9.09%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.40
-0.24(-9.09%)
Currency In USD
| Market Cap | 39.21M |
| Enterprise Value | 30.69M |
| P/E Ratio | -3.3 |
| PEG Ratio | -0.03 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 6.6 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.25 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.3 |
| Return On Equity | 31.14 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -90,000 |
| EBITDA | -25.01M |
| Net Income | -33.56M |
| Diluted EPS | -28.42 |
| Total Cash | 10.32M |
| Total Cash/Share | 0.25 |
| Total Debt | 185,000 |
| Total Debt/Equity | 0.01 |
| Current Ratio | 1.38 |
| Book Value Per Share | 0.37 |
| 52-Week Change | -89.45 |
| 52-Week High | 24 |
| 52-Week Low | 1.79 |
| Moving Average 50 Days | 2.43 |
| Moving Average 200 Days | 6.43 |
| Average Volume | 170,158 |
| Shares Outstanding | 1.21M |
| % Held by Institutions | 0.37 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.06 |
| Last Split Factor | 1:25 |
| Last Split Date | December 01, 2025 |